Barclays Rates Linde (LIN) Overweight, $577 Price Target

Barclays maintains an Overweight rating on Linde plc with a new price target of $577.00, a 15.76% upside from the current price.

By EarningsIQ Research Desk · Published Oct 16, 2026, 1:57 PM EDT

Reviewed by automated data checks against the source data. How we make and check alerts

Barclays rated Linde plc ($LIN) "Overweight" with a $577 price target on October 13, 2026.

Since the rating, $LIN is up 1.3% to date (from the $492.11 close on Oct 13, 2026).

LIN Linde plc

$498.43 +17.30% year to date

Daily close · Oct 16, 2026

Key Points

On October 13, 2026, Barclays reiterated its Overweight rating on Linde plc with a price target of $577.00.
Barclays's $577 price target implies 15.76% upside from Linde plc's ($LIN) current $498.44 share price.
As of October 16, 2026, Linde's shares traded at $498.44, about 13.6% below Barclays' target.
The next earnings report for Linde plc is scheduled for October 30, 2026.

Get $LIN trade alerts by text

We text you when insiders, Congress or big funds trade $LIN. Free.

Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Linde plc alert may contain errors. Disclosures

Barclays reiterated its Overweight rating on Linde plc (NasdaqGS: LIN) on October 13, 2026, setting a price target of $577.00. This target is 13.6% above the recent trading price of $498.44 as of October 16, 2026.

Other Institutional Activity in Linde plc

Several other institutional investors have recently adjusted their positions in Linde. Blackrock Inc. grew its holdings by 431,385 shares, ending with 37,301,875 shares valued at about $18.6 billion. State Street Corporation added 718,307 shares, bringing its total to 20,344,181 shares worth approximately $10.1 billion. Meanwhile, Capital Research Global Investors increased its stake by 1,378,855 shares, resulting in 17,430,716 shares valued at around $8.7 billion.

Linde plc Stock Up 1.1%

Linde's stock is currently trading at $498.44, which is below the new target set by Barclays. The stock's performance is particularly noteworthy as it remains below the target price, suggesting potential upside if the market aligns with analyst expectations.

12-month forecast

$LIN price target

Linde plc daily closes and this analyst's $577 target. Not advice.

Recent Earnings

Linde plc reported trailing twelve-month revenue of approximately $35.4 billion and an earnings per share (EPS) of $15.52. The company has a net margin of 20.4% and a return on equity (ROE) of 18.4%. The next earnings report is scheduled for October 30, 2026.

Dividend

Linde plc pays an annual dividend rate of $6.40, which corresponds to a dividend payout ratio of 40.0%.

Insider Buying and Selling at Linde plc

Insider activity at Linde includes several notable transactions. On March 10, 2026, Chief Operating Officer Sean Durbin sold 6,520 shares, valued at approximately $3.1 million. Officer Guillermo Bichara also sold 4,357 shares at an average price of $480.79, totaling about $2.1 million. In contrast, Director Paula Rosput Reynolds bought 100 shares at $479.12, amounting to $47,912 on August 18, 2026.

Analysts Set New Price Targets

On October 13, 2026, Barclays initiated its coverage of Linde with an Overweight rating and a price target of $577.00. Other firms have also adjusted their targets recently, with Keybanc initiating coverage at $542.00 on September 11, Argus Research maintaining a Buy rating with a target of $538.00 on September 28, and Citigroup maintaining a Buy rating with a target of $560.00 on October 7.

About Linde plc

Linde plc is an industrial gas company that operates globally, providing a range of atmospheric and process gases, including oxygen, nitrogen, and hydrogen. The company also designs and constructs process plants for various industries. With a workforce of over 64,000 employees, Linde plays a significant role in the specialty chemicals sector.

Bottom Line

Investors should keep an eye on Linde as it prepares for its next earnings report on October 30, 2026. The stock's current price is notably below the new price target set by Barclays, indicating potential for future growth.